Nipent and dehydration Patient Reports March 20, 2010

Nipent Side Effects Report #4655614-0
Nipent side effect was reported by a Health Professional from on Apr 29, 2005. Female patient, 34 years of age, weighting 121.3 lb, was diagnosed with graft versus host disease and was treated with Nipent. After drug was administered, patient experienced the following side effects: asthenia, dehydration, hepatic enzyme increased. Nipent dosage: 0.2857 MG/M2 (4 MG/M2, EVERY 2 WEEKS), INTRAVENOUS. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4708664-X
Nipent side effect was reported by a Health Professional from UNITED STATES on June 30, 2005. Male patient, 73 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: dehydration, fluid intake reduced, malaise, pyrexia, tumour lysis syndrome. Nipent dosage: 7.6 MG, INTRAVENOUS. During the same period patient was treated with CYTOXAN, ALEVE, ASPIRIN, FLOMAX, PROCARDIA, LOZOL, ALLOPURINOL, COMPAZINE. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4732526-5
Nipent side effect was reported by a Health Professional from UNITED STATES on July 29, 2005. Male patient, 73 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: dehydration, fluid intake reduced, malaise, pyrexia, tumour lysis syndrome. Nipent dosage: (7.6 MG), INTRAVENOUS. During the same period patient was treated with CYTOXAN, RITUXAN, ALEVE, ASPIRIN, FLOMAX, PROCARDIA, LOZOL, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4777451-9
Nipent side effect was reported by a Health Professional from UNITED STATES on Sept 09, 2005. Male patient, 73 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: dehydration, fluid intake reduced, malaise, pyrexia, tumour lysis syndrome. Nipent dosage: (7.6 MG), INTRAVENOUS. During the same period patient was treated with CYTOXAN, RITUXAN, ALEVE, ASPIRIN, FLOMAX, PROCARDIA, LOZOL, ALLOPURINOL. Patient was hospitalized. Patient recovered.


Nipent Side Effects Report #4819645-X
Nipent side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2005. Male patient, 64 years of age, weighting 199.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: abdominal pain , blood pressure decreased, chills, dehydration, diarrhoea, heart rate increased, pyrexia, renal failure, sepsis . Nipent dosage: 0.0952 MG (2 MG, Q21), INTRAVENOUS. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, COZAAR, RABEPRAZOLE, CALCIUM CARBONATE, ERGOCALCIFEROL, VERAPAMIL, URSODIOL. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4700213-5
Nipent side effect was reported by a Consumer or non-health professional from on June 15, 2005. Male patient, 63 years of age, weighting 231.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: blepharitis, cough, dehydration, febrile neutropenia, gastroenteritis , pleural effusion, wheezing. Nipent dosage: 0.1905 MG/M2 (4 MG/M2, Q 21 DAYS), INTRAVENOUS. During the same period patient was treated with RITUXAN, CYTOXAN. Patient was hospitalized. Patient recovered.

Nipent Side Effects Report #4816619-X
Nipent side effect was reported by a Health Professional from UNITED STATES on Oct 13, 2005. Male patient, 79 years of age, weighting 154.6 lb, was diagnosed with b-cell small lymphocytic lymphoma, chronic lymphocytic leukaemia and was treated with Nipent. After drug was administered, patient experienced the following side effects: atrial fibrillation , back pain , benign prostatic hyperplasia, citrobacter infection, dehydration, dilatation atrial, oedema peripheral, pain in extremity, pneumonia . Nipent dosage: 0.1905 MG/M2 (4 MG/M2,Q21D), INTRAVENOUS. During the same period patient was treated with RITUXAN, NORVASC, ASPIRIN, PROSCAR, VITORIN, LISINOPRIL, TOPROL. Patient was hospitalized. Patient recovered.